CovidVax

The updated list of
Covid-19 Vaccines

(including the latest news)
by Current Stageby Distributionby Category
Number of vaccines, at each stage:
still
developing
50+
testing
on animals
58
testing
on humans
49
ready for
distribution
0

Ready for distribution (0)

No vaccine has completed clinical trials yet, but some possible distribution dates have already been announced.

Testing on humans (49)

total people on clinical trials: 357801
vaccine researcher country started people
on trial
Ad26 Janssen (Johnson & Johnson) Belgium + USA Jul 13
2020		 61045
@ Ph. 3
AZD 1222 Jenner Institute (University of Oxford) UK Apr 23
2020		 47444
@ Ph. 3
mRNA BNT162b2 BioNTech + Pfizer Germany + USA Apr 20
2020		 44866
@ Ph. 2-3
Ad5-nCoV CanSino Biologics + Beijing Institute of BioTech China + Canada Mar 16
2020		 41678
@ Ph. 3
Sputnik V Gamaleya Research Institute Russia Jun 17
2020		 40248
@ Ph. 3
mRNA-1273 Moderna + NIAID USA Mar 16
2020		 30755
@ Ph. 3
Inactivated Sinovac China + Brazil Apr 13
2020		 25208
@ Ph. 3
Inactivated Beijing Institute of BioProducts (Sinopharm) China Apr 29
2020		 24448
@ Ph. 3
Inactivated Wuhan Institute of BioProducts (Sinopharm) China Apr 12
2020		 17056
@ Ph. 3
NVX-CoV2373 Novavax USA May 6
2020		 12035
@ Ph. 3
Inactivated Institute of Medical Biology + Chinese Academy of Medical Sciences Singapore + China May 15
2020		 1413
@ Ph. 1-2
Inactivated Bharat Biotech India Jul 13
2020		 1249
@ Ph. 1-2
Inactivated Beijing Minhai Biotech China Oct 2
2020		 1180
@ Ph. 2
DNA Zydus Cadila India Jul 13
2020		 1048
@ Ph. 1-2
VSV-S Israel Institute for Biological Research Israel Oct 26
2020		 1040
@ Ph. 1-2
RBD-Dimer Anhui Zhifei Longcom Biopharma + Institute of Microbiology Chinese Academy of Sciences China Jun 22
2020		 1000
@ Ph. 2
mRNA CureVac Germany Jun 17
2020		 859
@ Ph. 2
Protein subunit Instituto Finlay de Vacunas Cuba Aug 24
2020		 676
@ Ph. 1
S protein Sanofi Pasteur + GSK France + UK Sep 3
2020		 440
@ Ph. 1-2
S protein University of Queensland Australia Jul 14
2020		 336
@ Ph. 1
saRNA Imperial College London UK Jun 4
2020		 320
@ Ph. 1
mRNA People's Liberation Army Academy of Military Sciences China Jun 25
2020		 288
@ Ph. 1
VLP SpyBiotech + Serum Institute of India UK + India Aug 17
2020		 280
@ Ph. 1-2
DNA INO-4800 Inovio Pharma USA + China Apr 3
2020		 280
@ Ph. 1-2
VSV IAVI + Batavia + Merck USA Oct 22
2020		 252
@ Ph. 1
Inactivated Research Institute for Biological Safety Problems Republic of Kazakhstan Kazakhstan Sep 1
2020		 244
@ Ph. 1-2
GX-19 DNA Genexine Inc. + Binex South Korea + Indonesia Jun 17
2020		 190
@ Ph. 1-2a
PD-VLP Medicago Canada Jul 10
2020		 180
@ Ph. 1
RBD Kentucky BioProcessing (British American Tobacco) USA Jul 31
2020		 180
@ Ph. 1-2
RBD West China Hospital Sichuan University China Aug 28
2020		 168
@ Ph. 1
Trimeric S protein Clover Biopharma China Jun 19
2020		 150
@ Ph. 1
Ad5-nCoV Institute of Biotechnology + People's Liberation Army Academy of Military Sciences China Sep 29
2020		 144
@ Ph. 1
DNA oral Symvivo Canada Apr 30
2020		 112
@ Ph. 1
Peptide FBRI SRC VB VECTOR Russia Jul 27
2020		 100
@ Ph. 1-2
aAPC Shenzhen GenoImmune Medical Institute China Feb 15
2020		 100
@ Ph. 1
LV-SMENP-DC Shenzhen GenoImmune Medical Institute China Mar 24
2020		 100
@ Ph. 1
GRAd-COV2 ReiThera + Leukocare Italy + Germany + Belgium Aug 10
2020		 90
@ Ph. 1
Measles Vector Institut Pasteur France + Austria + USA Aug 10
2020		 90
@ Ph. 1
mRNA Lunar-Cov19 Arcturus Therapeutics + Duke-NUS USA + Singapore Jul 22
2020		 85
@ Ph. 1-2
S protein Adimmune Taiwan Aug 20
2020		 70
@ Ph. 1
S1-RBD-protein Covaxx + University of Nebraska Medical Center (UNMC) USA Sep 1
2020		 60
@ Ph. 1
DNA Osaka University + AnGes Japan + USA Jun 29
2020		 60
@ Ph. 1-2
VAAST oral Vaxart USA Sep 24
2020		 48
@ Ph. 1
CpG 1018 Medigen Vaccine Biologics Corp + NIAID Taiwan + USA Sep 01
2020		 45
@ Ph. 1
S protein Vaxine + Flinders University Australia + UK Jun 30
2020		 40
@ Ph. 1
peptides University Hospital Tuebingen Germany Sep 30
2020		 36
@ Ph. 1
hAd5 ImmunityBio + NantKwest USA Oct 19
2020		 35
@ Ph. 1
MVA-S encoded DZIF - German Center for Infection Research Germany Oct 20
2020		 30
@ Ph. 1
Inactivated Erciyes University Turkey 0
@ Ph. 
Latest updates on these vaccines:
Nov 24Brazil gathered enough infection data from a late-stage Sinovac's vaccine trial expecting to have results on its efficiency in early December
Nov 23Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective against coronavirus
Nov 20Pfizer and BioNTech expect to produce up to 50 million doses in 2020 and up to 1.3 billion doses by the end of 2021
Nov 20Pfizer-BioNTech announced they'll submit a request today to the US FDA for emergency use authorization of their mRNA vaccine
Nov 18BioNTech-Pfizer announced that after conducting the final analysis of their ongoing Phase 3 study their vaccine met all primary efficacy endpoints
Nov 17CoronaVac triggered a quick immune response but level of antibodies produced was lower than those who recovered from COVID-19
Nov 17Moderna announced today that the EMA has started a rolling review of mRNA-1273
Nov 16Moderna's vaccine meets its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study
Nov 16Moderna announced new data showing that mRNA-1273 remains stable at 2°to 8°C the temperature of a standard fridge for 30 days
Nov 15J&J initiated second global Phase 3 clinical trial of its vaccine by enrolling up to 60000 participants worldwide

Testing on animals (58)

vaccine researcher country started human
trials
AVI-205 AbVision USA
Unknown Adeleke University Nigeria
AdCOVID intranasal Altimmune + University of Alabama USA Apr
2020		 Q3
2020
Spike protein Axon Neuroscience Slovakia
Rabies vector Bharat Biotech + Thomas Jefferson University India + USA Apr
2020
DNA BioNet-Asia + Technovalia + Vax4COVID Alliance Thailand + France Apr
2020
mRNA Biocad Russia late Apr
2020
Unknown Catholic University + Millenium Institute of Immunology and Imm.therapy Chile
MVA Centro Nacional Biotecnologia (CNB-CSIC) Spain May
2020
Self amplifying RNA Chimeron Bio + George Madison University's National Center for Biodefense and Infectious Disease USA
mRNA China CDC + Tongji University China Feb
2020
DNA Chula Vaccine Research Center + National Research Council of Thailand Thailand May
2020
exoVACC Codiak BioSciences + Ragon Institute USA
srRNA Elixirgen Therapeutics USA
Unknown Emergex Vaccines + George Mason University's National Center for Biodefense and Infectious Diseases (NCIBD) UK + Canada
mRNA FBRI SRC VB VECTOR Russia
Subunit FBRI SRC VB VECTOR Russia
Measles Vector FBRI SRC VB VECTOR Russia
Recombinant vaccine based on influenza A virus FBRI SRC VB VECTOR Russia
VSV Vector FBRI SRC VB VECTOR Russia
Peptide Flow Pharma USA Apr
2020
MVA-VLP GeoVax + BravoVax USA + China Mar
2020		 Q4
2020
AAVCOVID Grousbeck Gene Therapy Center at Mass. Eye and Ear + AveXis USA + Spain May
2020
HSP70 HaloVax USA late Apr
2020
gp-96 Heat Biologics (Zolovax) USA Apr
2020
Dpx-Covid-19 IMV Canada Apr
2020		 Q3
2020
Spike-based Immuno Precise + LiteVax BV Canada + Holland Aug
2020
TaliCoVax19 InnoMedica Switzerland
Intranasal lentiviral vector vaccine Institut Pasteur + TheraVectys France
mRNA Max Planck Institute of Colloids and Interfaces Germany
Protein subunit Max-Planck Institute of Colloids and Interfaces Germany
Attenuated Meissa Vaccines INC USA Jun
2020
Avian IBV oral Migal Research Institute Israel Feb
2020		 Q3
2020
IMT504 NidoVax USA
TerraCoV2 Oragenics (Noachis Terra) + Aragen Bioscience USA
PDS - 0203 PDS Biotech USA
Unknown Precision Vaccines Program at Boston Children's Hospital USA
SK SK Bioscience South Korea Mar
2020		 Sep
2020
RBD Saiba Switzerland Mar
2020		 Aug
2020
mRNA Sanofi Pasteur + Translate Bio France + USA
Inactivated Selcuk University Turkey
CiVax Soligenix + University of Hawaii at Manoa USA
Recombinant Sorrento Therapeutics USA Mar
2020
S protein St. Petersburg Scientific Research Institute of Vaccines and Serums Russia Mar
2020
DNA Statens Serum Institut Denmark
Linear DNA Takis Biotech + Applied DNA Sciences Italy + USA Apr
2020		 Q4
2020
Unknown United Biomedical (UBI) + c19 Taiwan
Recombinant LVS University of California Los Angeles (Horwitz Lab) USA
PIV5 University of Georgia + University of Iowa USA Apr
2020
skin patch University of Pittsburgh USA Mar
2020		 Jun
2020
Adj Peptide VIDO-InterVac Canada Apr
2020		 Q4
2020
S protein Vabiotech Vietnam May
2020
Nanoparticles (vaults) Vault Pharma + University of California Los Angeles USA
Peptide Vaxil Bio Israel Mar
2020
S protein Verndari + University of California Davis USA Apr
2020
Unknown Vir Biotech + GSK USA + UK
Chimeric vaccine Vivaldi Biosciences + Esco Aster Pte Ltd USA + Singapore
S protein WRAIR + USAMRIID USA Mar
2020
Latest updates on these vaccines:
Nov 11SSI's vaccine is now ready to be tested in humans after showing promising results in preclinical studies
Nov 03Vabiotech's vaccine has been tested on 12 rhesus macaques and trials are expected to last around a month
Oct 16Scientists with the USAMRDC expect to begin Phase 1 clinical trials of WRAIR's vaccine in Q4 2020
Oct 15SanofiTranslate mRNA vaccine was tested in mice and macaques giving them protection against SARS-Cov-2
Oct 15SanofiTranslate MRT5500 induced high antibody levels in preclinical studies
Oct 08DPX-COVID-19 has the potential to improve the duration of the immune response and protect older adults and more vulnerable individuals
Oct 06PharmaJet's needle-free system will be used to deliver COVIGEN in a Phase 1 clinical trial in Australia
Sep 21BioNet's needle free vaccine study will be launched in WA by researchers from The University of Western Australia and Telethon Kids Institute
Sep 20Technovalia partnered with the Vax4COVID Alliance and BioNet to start a Phase 1 trial in Australia with COVIGEN
Sep 09Axon announced positive preclinical results confirming the efficacy of the vaccine on the live SARS-CoV-2 virus

Still in development (50+)

vaccine researcher country animal
trials		 human
trials
S protein AJ Vaccines Denmark
eVLP ARTES Biotech Germany
cVLP AdaptVac (PREVENT-nCoV EU consortium) Denmark + Netherlands + Germany Q4
2020
S1 - Fc AnyGo Technology China
Heat stable subunit Applied Biotech Institute USA
S1 or RBD Baylor College of Medicine USA
OMV BiOMVis + University of Trento Italy
intranasal Biocad + IEM Russia
RBD Biological E India
mRNA-LNP CanSino Biologics + Precision Nanosystems China + Canada
RNA Centro Nacional Biotecnologia (CNB-CSIC) Spain
Attenuated Codagenix + Serum Institute of India USA + India Q3
2020
DNA DIOSynVax + University of Cambridge UK
Measles Vector DZIF - German Center for Infection Research Germany
VLP Doherty Institute Australia
DNA Entos Pharma Canada + USA
S protein EpiVax + University of Georgia USA
VLP Fudan University + Shangai JiaoTong University China
RBD Fudan University + Shangai JiaoTong University China
RNA GeneOne Life Science + Houston Methodist South Korea + USA
Ii-Key peptide Generex + EpiVax Canada + USA
mRNA GreenLight Biosciences USA
AD5 S Greffex USA
ISR-50 ISR Sweden Q2
2020		 Q4
2020
Plasmid DNA Immunomic Therapeutics + EpiVax USA
VLP Imophoron + Bristol University UK
Attenuated Indian Immunolog. + Griffith University India + Australia
XWG-03 S protein Innovax + Xiamen University Netherlands + China + UK
NDV-SARS-CoV-2/Spike Intravacc + Wageningen Bioveterinary Research Holland
YF17D Vector KU Leuven Belgium
DNA Karolinska Institute (OpenCorona EU project) Sweden + Germany + Italy 2021
Nano particle LakePharma USA
DNA intranasal Mediphage Bioceuticals + University of Waterloo Canada
S protein National Institute of Infectious Disease Japan Japan
RBD-based Neovii + Tel Aviv University Switzerland + Israel
Unknown OSE Immunotherapeutics France
VLP OSIVAX France
S and M proteins OncoGen Romania
VLP Osaka University + BIKEN Japan
Inactivated Osaka University + BIKEN Japan
OMV Quadram Institute Bioscience UK
mRNA RNA immune USA
DNA Scancell UK Q1
2021
Inactivated Sinovac + Dynavax China + USA
AD5 S oral Stabilitech UK
APMV The Lancaster University UK UK
TNX-1800 Tonix Pharma USA
S protein UMN Pharma (Shionogi) Japan Q4
2020
Spike based University of Alberta Canada
Plant virus University of California San Diego USA
RBD University of Hong Kong + Xiamen University China Sep 1
2020
Dendritic cell-based University of Manitoba Canada
VLPs University of Sao Paulo Brasil
mRNA University of Tokyo + Daiichi Sankyo Japan
VSV - S University of Western Ontario Canada
M2SR University of Winsconsin + FluGen USA + India Q4
2020
eVLP VBI Vaccines USA + Canada Q4
2020
Inactivated Valneva + Dynavax France + USA Q4
2020
AD + HLA Valo Therapeutics UK
S protein Yisheng Biopharma China
ZIP-1642 Ziphius Therapeutics + Ghent University Belgium
Measles Vector Zydus Cadila India
mRNA intranasal eTheRNA + Epivax Belgium + USA + Canada Q1
2021
Plant produced iBio + CC-Pharming USA + China
Latest updates on these vaccines:
Nov 16PREVENT-nCoV consortium member AdaptVac announced that its vaccine has been successfully manufactured
Nov 05OSE announced successful completion of its human ex vivo study and expects to start clinical trial in Q1 2021
Nov 02VBI's initial adaptive Phase 1/2 clinical study of coronavirus vaccine program expected to begin around year-end 2020
Oct 27CambridgeUni received a multi-million dollar funding for clinical trial using PharmaJet's needle-free system to deliver vaccine
Oct 23Entos was awarded up to $5M in NRC IRAP funding to conduct Phase 1 clinical trial of its vaccine
Sep 17CambridgeUni's vaccine has shown excellent safety and immunogenicity in Phase 1-2 trials
Sep 10HongKongUni's nasal-spray vaccine will have phase 1 clinical trial recruiting about 100 volunteers
Sep 09HKU State Key Lab has partnered with Xiamen Uni and Wantai Biopharmaceutical to rapidly develop a vaccine
Aug 31Daiichi Sankyo was selected by AMED to develop a vaccine
Aug 28Scientists at Nottingham's two leading universities have announced plans to begin clinical trials of Scancell's vaccine in Q1 2021


contact | about | ©2020 CovidVax.org project